|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
PDL BioPharma, Inc. |
|---|---|
| Information provided by: | Facet Biotech |
| ClinicalTrials.gov Identifier: | NCT00024544 |
Purpose
The purpose of the study is to evaluate an investigational medication to treat chronic asthma. The research is being conducted at 20 clinical research sites in the US and is open to both men and women ages 18 to 70 years. Participants in the study will have a number of visits to a research site over an 8-month period. All study-related care and medication is provided to qualified participants at no cost. This includes all visits, examinations and laboratory work.
| Condition | Intervention | Phase |
|---|---|---|
|
Asthma |
Drug: anti-IL-4 monoclonal antibody (pascolizumab) |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
| Official Title: | A Phase I/II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of SB 240683 in Patients With Symptomatic Steroid-Naive Asthma |
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, California | |
| Bensch Research Associates | |
| Stockton, California, United States, 95207 | |
| Southern California Research | |
| Mission Viejo, California, United States, 92691 | |
| Allergy Research Foundation | |
| Los Angeles, California, United States, 90025 | |
| Clinical Trials of Orange Cnty., Inc. | |
| Orange, California, United States, 92868 | |
| Allergy and Asthma Associates Santa Clara Valley Research Center | |
| San Jose, California, United States, 95117 | |
| Allergy Associates Medical Group, Inc. | |
| San Diego, California, United States, 92120 | |
| United States, Colorado | |
| National Jewish Medical and Research Center | |
| Denver, Colorado, United States, 80206 | |
| United States, Illinois | |
| ICSL Clinical Studies | |
| Normal, Illinois, United States, 61761 | |
| United States, Massachusetts | |
| New England Clinical Studies | |
| N. Dartmouth, Massachusetts, United States, 02747 | |
| Respiratory Therapy and Pulmonary Clinical Research Brigham & Women's Hospital | |
| Boston, Massachusetts, United States, 02115 | |
| United States, Minnesota | |
| Clinical Research Institute | |
| Minneapolis, Minnesota, United States, 55402 | |
| United States, Missouri | |
| The Clinical Research Center, LLC | |
| St. Louis, Missouri, United States, 63141 | |
| United States, Nebraska | |
| Center for Allergy, Asthma and Immunology, Creighton University | |
| Omaha, Nebraska, United States, 68131 | |
| United States, New Jersey | |
| Princeton Center for Clinical Research | |
| Princeton, New Jersey, United States, 08540 | |
| United States, Oregon | |
| Allergy, Asthma, and Dermatology Research Center, LLC | |
| Lake Oswego, Oregon, United States, 97035 | |
| United States, Pennsylvania | |
| Valley Clinical Research Center | |
| Easton, Pennsylvania, United States, 18045 | |
| United States, Texas | |
| Clinical Trials North Houston | |
| Houston, Texas, United States, 77090 | |
| United States, Wisconsin | |
| University of Wisconsin Medical School | |
| Madison, Wisconsin, United States, 53792 | |
More Information
| Study ID Numbers: | 683-803 |
| Study First Received: | September 19, 2001 |
| Last Updated: | August 2, 2008 |
| ClinicalTrials.gov Identifier: | NCT00024544 History of Changes |
| Health Authority: | United States: Food and Drug Administration |
|
asthma anti-IL-4 monoclonal antibody pascolizumab |
|
Antibodies, Monoclonal Antibodies Hypersensitivity Lung Diseases, Obstructive Immunologic Factors Respiratory Tract Diseases |
Bronchial Diseases Lung Diseases Hypersensitivity, Immediate Asthma Immunoglobulins Respiratory Hypersensitivity |
|
Bronchial Diseases Immune System Diseases Immunologic Factors Physiological Effects of Drugs Asthma Pharmacologic Actions Antibodies, Monoclonal |
Lung Diseases, Obstructive Hypersensitivity Antibodies Respiratory Tract Diseases Lung Diseases Hypersensitivity, Immediate Respiratory Hypersensitivity |
